Literature DB >> 23312666

Rehabilitation of motor neuron disease.

Zachary Simmons1.   

Abstract

Amyotrophic lateral sclerosis (ALS), the most common adult motor neuron disease, is an acquired disorder that results in loss of function in multiple domains. Although there is no treatment that can halt or reverse this progressive condition, there are many opportunities for interventions that can lead to improved quality of life for the patient and caregiver. Physical and occupational therapy can assist with mobility and activities of daily living. Interventions by speech pathology can optimize nutrition and communication. Respiratory function can be managed noninvasively or invasively. Depression, hopelessness, anxiety, and other mental health issues can and should be aggressively addressed and treated. Many symptoms such as pseudobulbar affect, sialorrhea, constipation, spasticity, and cramps can be treated effectively with medications. Spirituality and religion are important issues to address, as are end-of-life concerns, including advance directives, hospice, and the dying process. In contrast to the discouraging view that "there is nothing we can do," a broad approach to management, through collaboration with a multidisciplinary team, will permit the ALS physician to make a meaningful difference in the lives of individuals living with ALS.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23312666     DOI: 10.1016/B978-0-444-52901-5.00041-1

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  5 in total

1.  Symptom management in amyotrophic lateral sclerosis: We can do better.

Authors:  Stephen A Goutman; Zachary Simmons
Journal:  Muscle Nerve       Date:  2017-08-30       Impact factor: 3.217

Review 2.  Patient-Perceived Outcomes and Quality of Life in ALS.

Authors:  Zachary Simmons
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

3.  Brain-computer interface (BCI) evaluation in people with amyotrophic lateral sclerosis.

Authors:  Lynn M McCane; Eric W Sellers; Dennis J McFarland; Joseph N Mak; C Steve Carmack; Debra Zeitlin; Jonathan R Wolpaw; Theresa M Vaughan
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-20       Impact factor: 4.092

4.  Patient-reported problematic symptoms in an ALS treatment trial.

Authors:  Divisha Raheja; Helen E Stephens; Erik Lehman; Susan Walsh; Chengwu Yang; Zachary Simmons
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-01-29       Impact factor: 4.092

5.  Interaction of physical function, quality of life and depression in Amyotrophic lateral sclerosis: characterization of a large patient cohort.

Authors:  Sonja Körner; Katja Kollewe; Susanne Abdulla; Antonia Zapf; Reinhard Dengler; Susanne Petri
Journal:  BMC Neurol       Date:  2015-05-16       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.